Lancet Capital, the first SBIC affiliated with an academic medical center, was founded in 1998 by William Golden and George Sing to create value for investors and founders/management of early stage biomedical portfolio companies.

Lancet invests in exceptional researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field. Lancet is able to offer value-adding human capital in the venture-building process by providing: